Every year at the beginning of April, I tell myself I must top up my Isa before the 5 April deadline. And all my friends tell me I must. My financial adviser tells me I must. Articles in the press and adverts on social media tell me I must. And every year on 6 April
Agendia, Inc., a world leader in precision oncology for breast cancer, announced today that an oral presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting revealed new data from the national FLEX registry that identify differences in tumor biology between ethnic groups that can lead to meaningful treatment decisions, reinforcing the need for appropriate representation of diverse patient populations in breast cancer studies.